GLUE
Monte Rosa Therapeutics Inc
NASDAQ · Biotechnology
$19.55
+0.65 (+3.44%)
Analyst Consensus
Strong Buy
15 analysts
Price Target
Analyst Price Target
+96.7% upside
Low Target
$28.40
Average Target
$38.45
High Target
$50.36
Current Price
$19.55
Current
$19.55
$19.55
Target
$38.45
$38.45
$28.40
$38.45 avg
$50.36